The structurally well characterized members of the family of the bridged metallocene procatalysts with cyclopentadienyl‐fluorenyl ligand framework constitute excellent examples for the investigation of the interrelation between the catalyst geometry and stereospecificity from a dynamic chain perspective. We have thus carefully selected a set of metallocenes, based on the increasing size of their β‐substituents and the choice of Zr and Hf as transition metals. By their application as polymerization catalysts we have been able to investigate the impact of the substituent size on the migratory behavior of the chain and stereospecific control of the corresponding catalysts. Through these investigations it has been demonstrated that the degree of freedom for the chain's lateral displacements, and the frequency of its back and forth migrations, varies largely with and is dependent on the steric bulk of the β‐positioned substituent and to the degree of the geometrical (stereo‐electronic) flexibility of the catalytic site with a given symmetry. It has been inferred from the experimental results that substituents, depending on their voluminosity and spatial expansion, interfer differently with the migratory function of the chain and can bring its migration, temporarily or permanently, to a halt (chain stationary insertion). The ratio of chain migratory insertion to chain stationary insertion and their prevalence in each individual case has the final saying about the degree and the type of the microtacticity of the resulting polymer chains (e.g. syndiotactic, syndiotactic containing isoblock, syndio‐isoblock, isotactic, and isotactic with syndioblock.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.